Atlas Trials

A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

Clinical trial NCT07753993 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07753993
Sponsor
AstraZeneca
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Kidney Disease
Start date
2026-08-28
Primary completion
2030-10-04
Enrollment
7000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.